Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Alliance Pharma Plc (APH) Ordinary 1p

Sell:77.30p Buy:78.00p 0 Change: 1.00p (1.30%)
FTSE AIM 100:0.37%
Market closed Prices as at close on 6 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:77.30p
Buy:78.00p
Change: 1.00p (1.30%)
Market closed Prices as at close on 6 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:77.30p
Buy:78.00p
Change: 1.00p (1.30%)
Market closed Prices as at close on 6 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Contact details

Address:
Avonbridge House, Bath Road
CHIPPENHAM
SN15 2BB
United Kingdom
Telephone:
+44 (01249) 466966
Website:
https://www.alliancepharmaceuticals.com/

Important dates

Future events
Interim dividend payment date 10 January 2020 10/01/20
Interim ex-dividend date 19 December 2019 19/12/19
Past events
Interim results 24 September 2019 24/09/19
Trading Announcement 17 July 2019 17/07/19
Final dividend payment date 11 July 2019 11/07/19
Final ex-dividend date 13 June 2019 13/06/19
AGM 23 May 2019 23/05/19
General meeting 23 May 2019 23/05/19
Annual report 16 April 2019 16/04/19
Final results 26 March 2019 26/03/19
Trading Announcement 21 January 2019 21/01/19
Interim dividend payment date 10 January 2019 10/01/19
Interim ex-dividend date 20 December 2018 20/12/18

General stock information

EPIC:
APH
ISIN:
GB0031030819
Market cap:
£410.73 million
Shares in issue:
526.58 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel

  • Peter Butterfield
    Chief Executive Officer, Executive Director
  • Andrew Franklin
    Chief Financial Officer, Executive Director
  • Stephen Kidner
    Chief Operating Officer, Chief Scientific Officer
  • Janice Timberlake
    Chief Human Resource Officer
  • Alex Duggan
    Chief Commercial Officer
  • Dan Thomas
    Chief Corporate Development Officer
  • Chris Chrysanthou
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.